Results 91 to 100 of about 1,202 (173)

An adiponectin-S1P autocrine axis protects skeletal muscle cells from palmitate-induced cell death

open access: yesLipids in Health and Disease, 2020
Background The prevalence of type 2 diabetes, obesity and their various comorbidities have continued to rise. In skeletal muscle lipotoxicity is well known to be a contributor to the development of insulin resistance.
Amy Botta   +4 more
doaj   +1 more source

Exploring the Relationship Between Adipocytokines and Endometrial Cancer: Identifying Correlations With Clinico‐Pathological Prognostic Factors

open access: yesCancer Medicine, Volume 14, Issue 13, July 2025.
Endometrial cancer is linked to obesity and chronic inflammation, potentially mediated by adipocytokines like adiponectin, leptin, IL6, and TNFα. This study examined mRNA expression of these markers and their receptors in cancerous versus benign endometrial tissue using qRT‐PCR.
Irene Ray   +9 more
wiley   +1 more source

Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions

open access: yesPhysiological Reports, Volume 13, Issue 11, June 2025.
Abstract Adiponectin (ADPN) is a pleiotropic hormone produced by adipose tissue involved in the control of body weight, energy expenditure, and feeding behaviors. Alongside a central effect, ADPN acts on peripheral organs such as the stomach, where it can favor gastric fundus relaxation, reinforcing central satiety signals.
R. Garella   +7 more
wiley   +1 more source

Aging alters the effect of adiponectin receptor signaling on bone marrow‐derived mesenchymal stem cells

open access: yesAging Cell, Volume 24, Issue 2, February 2025.
Increased APN levels, or differential Adipor transcriptional activity, and altered distribution of these receptors, along with subsequent activation of downstream pathways, pathologically tip the balance to favor delayed bone defect repair. Abstract Adiponectin receptor signaling represents a promising therapeutic target for age‐related conditions such
Hanghang Liu   +7 more
wiley   +1 more source

AdipoRon prevents myostatin‐induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line

open access: yesPhysiological Reports, 2019
Liver diseases such as non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) are characterized by excess hepatic accumulation of lipid droplets and triglycerides which are associated with defective insulin action.
Xin‐Hua Liu   +3 more
doaj   +1 more source

Effects of AdipoRon administration on phosphorylation level of AMP-dependent protein kinase (AMPK) in mouse skeletal muscles.

open access: yes, 2018
Abbreviations are the same as in Fig 4. n = 7 and 5 in vehicle-control and AdipoRon-administrated groups, respectively.
Shingo Yokoyama (5849048)   +10 more
core   +1 more source

Effect of goose adiponectin-derived peptide gADP3 on LPS-induced intestinal injury in goose

open access: yesItalian Journal of Animal Science
The present study aims to evaluate the effects of goose adiponectin-derived peptide gADP3 on lipopolysaccharide (LPS) induced goose intestinal injury. Intestinal injury was induced in geese by intraperitoneal injection of LPS.
Zhongzan Cao   +6 more
doaj   +1 more source

Efficacy of ADIPOR1 and ADIPOR2 peptide‐agonist AdipoRon in preventing contracture in a rabbit model of arthrofibrosis

open access: yesJournal of Orthopaedic Research
AbstractAdipoRon is an adiponectin receptor 1, 2 (ADIPOR1 and ADIPOR2) agonist with potential antifibrotic effects. Whether AdipoRon can mitigate joint stiffness in a rabbit model of arthrofibrosis is unknown. We examined the efficacy of intravenous (IV) AdipoRon at mitigating contracture in a rabbit model of knee arthrofibrosis.
Harold I. Salmons   +11 more
openaire   +2 more sources

Effects of AdipoRon administration on C2C12 myotubes with or without knockdown of adiponectin receptor (AdipoR).

open access: yes, 2018
Final concentration of AdipoRon was set at 0, 5, 10 and 20 μM in the differentiation medium. A: Effects of AdipoRon on C2C12 myotubes morphology with or without AdipoR knockdown. B: Effects of AdipoRon on protein content in C2C12 myotubes with or without
Shingo Yokoyama (5849048)   +10 more
core   +1 more source

Adiponectin receptor agonist, AdipoRon, reduces the growth of prostate cancer cells and patient-derived organoids.

open access: yes
Low adiponectin levels in obese men are associated with an incidence of aggressive prostate cancer (PCa). Despite significant advances in PCa treatment, some cases become resistant, making the development of new therapies crucial.
de Lima, Micheli Canuto   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy